visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Alzheon, Inc.

    Get Full Access

    Description

    • Alzheon, Inc. is committed to developing innovative medicines by directly addressing the underlying pathology of devastating neurodegenerative disorders. Our lead Alzheimers clinical candidate, ALZ-801, is a Phase 3-ready, first-in-class, small molecule oral inhibitor of amyloid aggregation and neurotoxicity hallmarks of Alzheimers disease. ALZ-801 is a novel prodrug that builds on the safety and efficacy profile of the active compound tramiprosate, which has been evaluated in clinical trials involving over 2,000 Alzheimers patients. Our clinical expertise and technology platform is focused on developing drug candidates using a precision medicine approach based on individual genetic and biological information to advance therapies with the greatest impact for patients. www.alzheon.com
    • location

      Headquarters:111 Speen Street Suite 306, Framingham, Massachusetts, United States

      More
    • Alzheon, Inc. phone

      Phone Number: +1 508-861-7709

    • Alzheon, Inc. website

      Website: https://www.alzheon.com

    • Alzheon, Inc. employees

      Employees:12

    • Alzheon, Inc. revenue

      Revenue:$10 - 50M

    • Alzheon, Inc. legal name

      Legal Name:Alzheon, Inc.

    • Alzheon, Inc.'s Social Media

      Alzheon, Inc. linkedin Alzheon, Inc. twitter
    • done Is this data correct?

    • |  NAICS Code: 541714  |

      Show More
    Person level website identification

    Chief Strategy Officer for Alzheon, Inc.

    John Hey

    Chief Strategy Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    John Hey

    Chief Strategy Officer

    Ken Mace

    Chief Financial Officer

    Diane Jorkasky

    Board Member

    Pat Kesslak

    Vice President Clinical Development And Medical Affairs

    Jean Schaefer

    Director Program Management

    Frequently Asked Questions regarding Alzheon, Inc.

    • Where are Alzheon, Inc.'s Headquarters?

      Alzheon, Inc.'s Headquarters are in 111 Speen Street Suite 306,Framingham,Massachusetts,United States

    • What is Alzheon, Inc.'s phone number?

      Alzheon, Inc.'s phone number is +1 508-861-7709

    • What is Alzheon, Inc.'s official website?

      Alzheon, Inc.'s official website is https://www.alzheon.com

    • What is Alzheon, Inc.'s Revenue?

      Alzheon, Inc.'s revenue is $10 - 50M

    • What is Alzheon, Inc.'s NAICS code?

      Alzheon, Inc.'s NAICS code is 541714

    • How many employees are working in Alzheon, Inc.

      Alzheon, Inc. has 12 employees

    • What is Alzheon, Inc.'s Industry?

      Alzheon, Inc. is in the industry of Biotechnology

    • Who is Alzheon, Inc.'s Chief Strategy Officer?

      Alzheon, Inc.'s Chief Strategy Officer is John Hey

    Company Directory